FDA Inspection 1169023 - Marlinz Pharma, LLC - May 04, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Marlinz Pharma, LLC

Record Details

This FDA Inspection record concerns Marlinz Pharma, LLC, with an inspection on May 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Marlinz Pharma, LLC
Inspection Date: May 4, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 4b5ea71f-b7cf-4f34-b34b-5fea311505bb

Violation Codes2

21 CFR 211.198(a)21 CFR 211.198(b)(1)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Marlinz Pharma, LLCMay 4, 2022